Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors

Background Tumor cells can drive the senescence of effector T cells by unbalancing their lipid metabolism, thereby limiting adoptive T cell therapy and contributing to tumor immune evasion. Our objective is to provide a feasible strategy for enhancing T cell treatment efficacy against solid tumors.M...

Full description

Saved in:
Bibliographic Details
Main Authors: Lu Wang, Li Ding, Gang Chen, Zhou Xu, Yanqing Zhang, Bin Deng, Xiya Wang, Yemin Xu, Mengyue Wu, Yinhe Xia, Zhennan Cao, Ruilong Song
Format: Article
Language:English
Published: BMJ Publishing Group 2025-01-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/1/e010403.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556533504114688
author Lu Wang
Li Ding
Gang Chen
Zhou Xu
Yanqing Zhang
Bin Deng
Xiya Wang
Yemin Xu
Mengyue Wu
Yinhe Xia
Zhennan Cao
Ruilong Song
author_facet Lu Wang
Li Ding
Gang Chen
Zhou Xu
Yanqing Zhang
Bin Deng
Xiya Wang
Yemin Xu
Mengyue Wu
Yinhe Xia
Zhennan Cao
Ruilong Song
author_sort Lu Wang
collection DOAJ
description Background Tumor cells can drive the senescence of effector T cells by unbalancing their lipid metabolism, thereby limiting adoptive T cell therapy and contributing to tumor immune evasion. Our objective is to provide a feasible strategy for enhancing T cell treatment efficacy against solid tumors.Methods In this study, liposomal arachidonyl trifluoromethyl ketone (ATK) was anchored onto the adoptive T cell surface via bioorthogonal reactions, aiming to specifically inhibit the group IVA cytosolic phospholipase A2α (cPLA2α), a key enzyme facilitating phospholipid metabolism and senescent state of T cells.Results The surface engineering exerted rare side effects on the activation and migration of T cells, but local and sustained extravasation of ATK downregulated cPLA2α expression, reprogrammed lipid metabolism, and inhibited lipid droplet accumulation. This endows T cells with delayed senescence and declined apoptosis to maintain their tumor-killing potency. Systemic administration of surface-engineered T cells resulted in superior infiltration in solid tumors and improved antitumor efficacy by enhancing the secretion of cytotoxic molecules, thereby prolonging the survival of mice bearing colorectal carcinoma and melanoma xenografts.Conclusions Lipid-metabolically remodeled T cells with delayed senescence increase efficacy in tumor microenvironment, highlighting a novel strategy for solid tumor immunotherapy.
format Article
id doaj-art-de00f826a00746f78292216def560f9d
institution Kabale University
issn 2051-1426
language English
publishDate 2025-01-01
publisher BMJ Publishing Group
record_format Article
series Journal for ImmunoTherapy of Cancer
spelling doaj-art-de00f826a00746f78292216def560f9d2025-01-07T08:00:09ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262025-01-0113110.1136/jitc-2024-010403Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumorsLu Wang0Li Ding1Gang Chen2Zhou Xu3Yanqing Zhang4Bin Deng5Xiya Wang6Yemin Xu7Mengyue Wu8Yinhe Xia9Zhennan Cao10Ruilong Song11Department of Gastroenterology, Northern Jiangsu People`s Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, People`s Republic of ChinaCollege of Bioscience and Biotechnology, Yangzhou University, Yangzhou, Jiangsu, People`s Republic of ChinaQingdao Key Laboratory of Materials for Tissue Repair and Rehabilitation, School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao, Shandong, People`s Republic of ChinaQingdao Key Laboratory of Materials for Tissue Repair and Rehabilitation, School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao, Shandong, People`s Republic of ChinaMedical College, Yangzhou University, Yangzhou, Jiangsu, People`s Republic of ChinaDepartment of Gastroenterology, Northern Jiangsu People`s Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, People`s Republic of ChinaDepartment of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, People`s Republic of ChinaDepartment of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, People`s Republic of ChinaDepartment of Anesthesiology, The Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, People`s Republic of ChinaQingdao Key Laboratory of Materials for Tissue Repair and Rehabilitation, School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao, Shandong, People`s Republic of ChinaDepartment of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, People`s Republic of ChinaInstitute of Comparative Medicine, College of Veterinary Medicine, Yangzhou University, Yangzhou, Jiangsu, People`s Republic of ChinaBackground Tumor cells can drive the senescence of effector T cells by unbalancing their lipid metabolism, thereby limiting adoptive T cell therapy and contributing to tumor immune evasion. Our objective is to provide a feasible strategy for enhancing T cell treatment efficacy against solid tumors.Methods In this study, liposomal arachidonyl trifluoromethyl ketone (ATK) was anchored onto the adoptive T cell surface via bioorthogonal reactions, aiming to specifically inhibit the group IVA cytosolic phospholipase A2α (cPLA2α), a key enzyme facilitating phospholipid metabolism and senescent state of T cells.Results The surface engineering exerted rare side effects on the activation and migration of T cells, but local and sustained extravasation of ATK downregulated cPLA2α expression, reprogrammed lipid metabolism, and inhibited lipid droplet accumulation. This endows T cells with delayed senescence and declined apoptosis to maintain their tumor-killing potency. Systemic administration of surface-engineered T cells resulted in superior infiltration in solid tumors and improved antitumor efficacy by enhancing the secretion of cytotoxic molecules, thereby prolonging the survival of mice bearing colorectal carcinoma and melanoma xenografts.Conclusions Lipid-metabolically remodeled T cells with delayed senescence increase efficacy in tumor microenvironment, highlighting a novel strategy for solid tumor immunotherapy.https://jitc.bmj.com/content/13/1/e010403.full
spellingShingle Lu Wang
Li Ding
Gang Chen
Zhou Xu
Yanqing Zhang
Bin Deng
Xiya Wang
Yemin Xu
Mengyue Wu
Yinhe Xia
Zhennan Cao
Ruilong Song
Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors
Journal for ImmunoTherapy of Cancer
title Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors
title_full Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors
title_fullStr Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors
title_full_unstemmed Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors
title_short Lipid metabolic remodeling delays senescence of T cells to potentiate their immunity against solid tumors
title_sort lipid metabolic remodeling delays senescence of t cells to potentiate their immunity against solid tumors
url https://jitc.bmj.com/content/13/1/e010403.full
work_keys_str_mv AT luwang lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT liding lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT gangchen lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT zhouxu lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT yanqingzhang lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT bindeng lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT xiyawang lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT yeminxu lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT mengyuewu lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT yinhexia lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT zhennancao lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors
AT ruilongsong lipidmetabolicremodelingdelayssenescenceoftcellstopotentiatetheirimmunityagainstsolidtumors